AN2 Therapeutics Inc banner

AN2 Therapeutics Inc
NASDAQ:ANTX

Watchlist Manager
AN2 Therapeutics Inc Logo
AN2 Therapeutics Inc
NASDAQ:ANTX
Watchlist
Price: 1.06 USD 0.95% Market Closed
Market Cap: $29m

Cash Flow Statement

Cash Flow Statement
AN2 Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(41)
(49)
(54)
(60)
(65)
(66)
(65)
(61)
(51)
(45)
(37)
(34)
Stock-Based Compensation
4
6
7
8
8
5
5
5
8
8
8
7
Other Non-Cash Items
4
5
5
6
6
5
5
5
5
5
6
5
Change in Working Capital
4
5
7
10
6
1
(1)
(5)
(3)
(2)
(4)
(1)
Cash from Operating Activities
(33)
N/A
(38)
-15%
(42)
-8%
(44)
-6%
(53)
-21%
(59)
-11%
(61)
-3%
(61)
0%
(49)
+19%
(42)
+15%
(35)
+16%
(30)
+16%
Investing Cash Flow
Other Items
(22)
(25)
23
(38)
(43)
(28)
(19)
61
55
38
27
15
Cash from Investing Activities
(22)
N/A
(25)
-14%
23
N/A
(38)
N/A
(43)
-15%
(28)
+36%
(19)
+31%
61
N/A
55
-11%
38
-31%
27
-28%
15
-45%
Financing Cash Flow
Net Issuance of Common Stock
70
7
19
85
85
85
66
0
0
0
0
0
Other
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
70
N/A
7
-90%
19
+161%
85
+343%
85
0%
85
+0%
66
-22%
0
-100%
0
+745%
0
-77%
0
N/A
0
+31%
Change in Cash
Net Change in Cash
15
N/A
(56)
N/A
0
N/A
4
+1 810%
(12)
N/A
(2)
+83%
(14)
-596%
0
N/A
6
+1 333%
(4)
N/A
(8)
-95%
(14)
-82%
Free Cash Flow
Free Cash Flow
(33)
N/A
(38)
-15%
(42)
-8%
(44)
-6%
(53)
-21%
(59)
-11%
(61)
-3%
(61)
0%
(49)
+19%
(42)
+15%
(35)
+16%
(30)
+16%